PsyPost on MSN

“Major problem”: Ketamine fails to outperform placebo for treating severe depression in new clinical trial

A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...
ascopubs.org

Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled Trial

Liability Risks of Ambient Clinical Workflows With Artificial Intelligence for Clinicians, Hospitals, and Manufacturers This single-center randomized clinical trial was conducted at its outpatient ...
Psychology Today

Beyond Trial and Error: How Genes Guide Depression Treatment

Depression affects millions globally, presenting a significant challenge for effective treatment. Traditional approaches often rely on trial and error to find ...
News-Medical.Net on MSN

GeneSight test-guided treatment leads to faster remission and response in patients with depression

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
TMCnet

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

Published in the Oct. 30, 2025 edition of Frontiers in Pharmacology, the new post-hoc analysis showed that patients who took the GeneSight test were at any given time during the 24-week study period ...